The financial trajectory of the exosome therapy market is decoupling from the broader, slower-growing regenerative medicine ...
LOI from the Department of Commerce’s CHIPS Program Includes Proposed $277 Million of Federal Funding and a $1.3 Billion Senior Secured Loan from the CHIPS Act By 2030, Transaction Enables Largest ...